ALTANA PHARMA AG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 4251
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
B01F MIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING 141
 
  
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
  
 
C07K PEPTIDES 1135
 
  
 
G03C PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES 145
 
  
 
G07G REGISTERING THE RECEIPT OF CASH, VALUABLES, OR TOKENS 117

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8044065 Benzothienopyridines for use as inhibitors of Eg5 kinesinMar 30, 10Oct 25, 11[A61K]
7162432 System and method for using psychological significance pattern information for matching with target informationJul 05, 01Jan 09, 07[G07G]
5432182 Compounds substituted quinoline derivativesJan 29, 92Jul 11, 95[A61K, A01N]
5425580 Dosage form for micro-bubble echo contrast agentsAug 02, 94Jun 20, 95[B01F]
5395732 Silver halide photographic materialsJun 04, 92Mar 07, 95[G03C]
5387746 Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereofNov 12, 92Feb 07, 95[A61K, C07K]
5346904 Sulphonyl compoundNov 04, 92Sep 13, 94[A61K, C07D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2010/0280,002 AMINOPYRIDINE-DERIVATIVES AS INDUCTIBLE NO-SYNTHASE INHIBITORSAbandonedJul 14, 10Nov 04, 10[A61K, A61P]
2010/0216,790 IMIDAZOPYRIDINE-DERIVATIVES AS INDUCIBLE NO-SYNTHASE INHIBITORSAbandonedMay 03, 10Aug 26, 10[A61K, A61P]
7781453 Aminopyridine-derivativesExpiredNov 16, 07Aug 24, 10[A61K]
7709488 Imidazopyridine-derivatives as inducible no-synthase inhibitorsExpiredSep 27, 07May 04, 10[A61K, C07D, A61P]
7524973 Nitrate esters of phenylaminothiophenacetic acid derivativesExpiredFeb 17, 04Apr 28, 09[C07D]
2009/0036,482 Imidazopyridine-derivatives as inductible no-synthase inhibitorsAbandonedSep 26, 08Feb 05, 09[A61K, A61P]
7468377 Imidazopyridine-derivatives as inductible no-synthase inhibitorsExpiredSep 30, 04Dec 23, 08[A01N]
2008/0242,681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase InhibitorsAbandonedJan 19, 05Oct 02, 08[A61K, C07D, A61P]
2008/0167,316 6-Heteroaryl-1,2,3,4,4A, 10B-Hexahydrophenanthridines as Pde4-Inhibitors for the Treatment of Inflammatory DisordersAbandonedMar 01, 06Jul 10, 08[A61K, C07D, A61P]
2008/0161,338 Novel Pyrrolodihydroisoquinolines as Pde 10 InhibitorsAbandonedJan 11, 06Jul 03, 08[A61K]
7390819 Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitorsExpiredFeb 24, 04Jun 24, 08[A61K]
2008/0125,452 Indolopyridines,Benzofuranopyridines and BenzothienopyridinesAbandonedJan 26, 06May 29, 08[A61K, C07D]
2008/0125,460 Imidazopyridine-Derivatives As Inducible No-Synthase InhibitorsAbandonedSep 30, 04May 29, 08[A61K, C07D, A61P]
2008/0119,505 Novel 6-PyridylphenanthridinesAbandonedJan 31, 06May 22, 08[A61K, C07D]
2008/0119,510 Substituted Imidazo [4,5-B] Pyridines As Inhibitors Of Gastric Acid SecretionAbandonedDec 06, 05May 22, 08[A61K, C07D]
2008/0113,962 Condensed Tricyclic Benzimidazoles For the Treatment of Gastrointestinal DisordersAbandonedSep 30, 05May 15, 08[A61K, C07D]
2008/0113,963 Cyclic benzimidazolesAbandonedNov 01, 07May 15, 08[A61K, C07D]
2008/0114,020 Difluoro-Substituted ImidazopyridinesAbandonedOct 13, 05May 15, 08[A61K, C07D, A61P]
2008/0108,652 Imidazo (4,5-B) pyridine-derivatives as inducible no-synthase inhibitorsAbandonedDec 17, 07May 08, 08[A61K, A61P]
2008/0102,133 Oral Pharmaceutical Preparation for Proton Pump AntagonistsAbandonedSep 30, 05May 01, 08[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.